Undiluted I.V.-Hepabig inj not checked

GC Biopharma Corp

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“undiluted I.V.-Hepabig inj(GC5103) 10,000 International Unit”In the company’s words, NCT05686759 on ClinicalTrials.gov
Tested for
Hepatitis B
Main trialPhase 3
“The purpose of this study is to evaluate the efficacy and safety of undiluted intravenous infusion of I.V.-Hepabig inj. in post-liver transplant patients”In the company’s words, NCT05686759 on ClinicalTrials.gov

Other drugs for Hepatitis B

All 41 drugs for Hepatitis B

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Jun 2026 A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 20 Nov 2026 · EU trials register (CTIS) updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow Undiluted I.V.-Hepabig inj

Following is part of Solo: you see every change to Undiluted I.V.-Hepabig inj the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in